Cargando…
SARS-CoV-2 (COVID-19) as a Predictor of Neuroinflammation and Neurodegeneration: Potential Treatment Strategies
The SARS-CoV-2 (COVID-19) pandemic has attracted attention to the challenge of neuroinflammation as an unavoidable component of viral infections. Acute neuroinflammatory responses include activation of resident tissue macrophages in the CNS followed by release of a variety of cytokines and chemokine...
Autores principales: | Putilina, M. V., Grishin, D. V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8219508/ https://www.ncbi.nlm.nih.gov/pubmed/34176996 http://dx.doi.org/10.1007/s11055-021-01108-z |
Ejemplares similares
-
SARS-CoV-2, COVID-19 and Neurodegeneration
por: Tönges, Lars, et al.
Publicado: (2022) -
SARS-CoV-2, long COVID, prion disease and neurodegeneration
por: Zhao, Yuhai, et al.
Publicado: (2022) -
SARS‐CoV‐2, aging, and Post‐COVID‐19 neurodegeneration
por: Strong, Michael J.
Publicado: (2022) -
SARS-CoV-2, the blood-brain barrier, and neuroinflammation
por: Banks, William A
Publicado: (2023) -
Iron, Neuroinflammation and Neurodegeneration
por: Ward, Roberta J., et al.
Publicado: (2022)